US Patent Issued to NiKang Therapeutics on June 17 for "Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors" (Delaware Inventor)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,026, issued on June 17, was assigned to NiKang Therapeutics Inc. (Wilmington, Del.).

"Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors" was invented by Yan Lou (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides certain sulfonamido derivatives that are Cyclin-dependent kinase 2 (CDK2) inhibitors of Formula (I):for the treatment of diseases treatable by inhibition of CDK2. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds."

The patent was filed on March 24, 2023, under Application No. 18/189,380.

*For further information, inc...